Biblio

Found 16 results
Sort by: Author Title Type [ Year (Desc)]
Filters: Author is Barkhof, F  [Clear All Filters]
2011
Kilsdonk ID, Barkhof F, Wattjes MP. 2010 revisions to McDonald criteria for diagnosis of multiple sclerosis: impact of 3-Tesla magnetic resonance imaging. Ann Neurol [Internet]. 2011;70:182-183. Available from: http://www.hubmed.org/display.cgi?uids=21710623
Reekers JA, Lee MJ, Belli AM, Barkhof F. Cardiovascular and interventional radiological society of europe commentary on the treatment of chronic cerebrospinal venous insufficiency. Cardiovasc Intervent Radiol [Internet]. 2011;34:1-2. Available from: http://www.hubmed.org/display.cgi?uids=21136256
Uitdehaag BM, Barkhof F, Coyle PK, Gardner JD, Jeffery DR, Mikol DD. The changing face of multiple sclerosis clinical trial populations. Curr Med Res Opin [Internet]. 2011;27:1529-1537. Available from: http://www.hubmed.org/display.cgi?uids=21671851
Smolders J, Hupperts R, Barkhof F, Grimaldi LM, Holmoy T, Killestein J, Rieckmann P, Schluep M, Vieth R, Hostalek U, et al. Efficacy of vitamin D(3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial. J Neurol Sci [Internet]. 2011;311:44-49. Available from: http://www.hubmed.org/display.cgi?uids=21620416
Hulst HE, Schoonheim MM, Roosendaal SD, Popescu V, Schweren LJ, van der Werf YD, Visser LH, Polman CH, Barkhof F, Geurts JJ, et al. Functional adaptive changes within the hippocampal memory system of patients with multiple sclerosis. Hum Brain Mapp [Internet]. 2011. Available from: http://www.hubmed.org/display.cgi?uids=21898674
Schoonheim MM, Geurts JJ, Landi D, Douw L, van der Meer ML, Vrenken H, Polman CH, Barkhof F, Stam CJ. Functional connectivity changes in multiple sclerosis patients: A graph analytical study of MEG resting state data. Hum Brain Mapp [Internet]. 2011. Available from: http://www.hubmed.org/display.cgi?uids=21954106
Seewann A, Vrenken H, Kooi EJ, van der Valk P, Knol DL, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ. Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis. Mult Scler [Internet]. 2011;17:1202-1210. Available from: http://www.hubmed.org/display.cgi?uids=21561955
van den Elskamp IJ, Knol DL, Uitdehaag BM, Barkhof F. Modeling MR Imaging Enhancing-Lesion Volumes in Multiple Sclerosis: Application in Clinical Trials. AJNR Am J Neuroradiol [Internet]. 2011. Available from: http://www.hubmed.org/display.cgi?uids=22051810
Ropele S, de Graaf W, Khalil M, Wattjes MP, Langkammer C, Rocca MA, Rovira A, Palace J, Barkhof F, Filippi M, et al. MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging [Internet]. 2011;34:13-21. Available from: http://www.hubmed.org/display.cgi?uids=21698703
Kappos L, Li D, Calabresi PA, O'Connor P, Bar-Or A, Barkhof F, Yin M, Leppert D, Glanzman R, Tinbergen J, et al. Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet [Internet]. 2011;378:1779-1787. Available from: http://www.hubmed.org/display.cgi?uids=22047971
Liguori M, Meier DS, Hildenbrand P, Healy BC, Chitnis T, Baruch NF, Khoury SJ, Weiner HL, Bakshi R, Barkhof F, et al. One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis. J Neurol Neurosurg Psychiatry [Internet]. 2011;82:1125-1131. Available from: http://www.hubmed.org/display.cgi?uids=21429902